Oleuropein as a Therapeutic Agent for Non-alcoholic Fatty Liver Disease During Hepatitis C-Reference-Cited by-同舟云学术

Oleuropein as a Therapeutic Agent for Non-alcoholic Fatty Liver Disease During Hepatitis C

Published:2023-06-01 Issue:4 Volume:33 Page:688-695
ISSN:1981-528X
Container-title:Revista Brasileira de Farmacognosia
language:en
Short-container-title:Rev. Bras. Farmacogn.

Author:

Sotoudeheian Mohammadjavad^ORCID,Hoseini SeyedAhmad^ORCID,Mirahmadi Seyed-Mohamad-Sadegh^ORCID,Farahmandian Navid^ORCID,Pazoki-Toroudi Hamidreza^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Pharmacology, Toxicology and Pharmaceutics

Link

https://link.springer.com/content/pdf/10.1007/s43450-023-00396-5.pdf

Reference65 articles.

1. Adinolfi LE, Rinaldi L, Guerrera B, Restivo L, Marrone A, Giordano M, Zampino R (2016) NAFLD and NASH in HCV infection: prevalence and significance in hepatic and extrahepatic manifestations. Int J Mol Sci 17:803. https://doi.org/10.3390/ijms17060803

2. Ahamad J, Toufeeq I, Khan MA, Ameen MSM, Anwer ET, Uthirapathy S, Mir SR, Ahmad J (2019) Oleuropein: a natural antioxidant molecule in the treatment of metabolic syndrome. Phytother Res 33:3112–3128. https://doi.org/10.1002/ptr.6511

3. Al-Karaki R, Awadallah A, Saleh M, Nasr M (2019) Novel oleuropein nanocapsular formulation: preparation, characterization and anticolon cancer activity. J App Pharm 11:1-8. http://dx.doi.org/https://doi.org/10.21065/19204159/11.01

4. Allen CN, Arjona SP, Santerre M, Sawaya BE (2022) Hallmarks of metabolic reprogramming and their role in viral pathogenesis. Viruses 14:602. https://doi.org/10.3390/v14030602

5. Boufissiou A, Abdalla M, Sharaf M, Al-Resayes SI, Imededdine K, Alam M, Yagi S, Azam M, Yousfi M (2022) In-silico investigation of phenolic compounds from leaves of Phillyrea angustifolia L. as a potential inhibitor against the SARS-CoV-2 main protease (Mpro PDB ID: 5R83) using a virtual screening method. J Saudi Chem Soc 26:101473. https://doi.org/10.1016/j.jscs.2022.101473

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galectin-3 and Severity of Liver Fibrosis in Metabolic Dysfunction-Associated Fatty Liver Disease;Protein & Peptide Letters;2024-04

2. Targeting SIRT1 by Scopoletin to Inhibit XBB.1.5 COVID-19 Life Cycle;Current Reviews in Clinical and Experimental Pharmacology;2024-03-01

3. Gastroprotective Chitosan Nanoparticles Loaded with Oleuropein: An In Vivo Proof of Concept;Pharmaceutics;2024-01-22

4. Understanding the Role of Galectin-1 in Heart Failure: A Comprehensive Narrative Review;Current Cardiology Reviews;2024-01

5. Acute sickle cell hepatopathy: a case report and literature review;Journal of the National Medical Association;2023-10